Showing 2461-2470 of 2527 results for "".
- ProtoKinetix Enters 3rd Phase of Retinal Cell Replacement Therapy Testing at UBChttps://modernod.com/news/protokinetix-enters-3rd-phase-of-retinal-cell-replacement-therapy-testing-at-ubc/2479948/ProtoKinetix has entered into the third phase of testing in retinal cell replacement therapy at the University of British Columbia. Due to the positive results from the first two phases of testing where the AAGP-treated cells showed a dramatic increase in survivability versus untreated cells over
- Astellas Announces Acquisition of Quethera, Maker of Gene Therapy Program for Glaucomahttps://modernod.com/news/astellas-announces-acquisition-of-quethera-maker-of-gene-therapy-program-for-glaucoma/2479949/Astellas Pharma has acquired Quethera, a gene therapy company headquartered in the United Kingdom that is focused on developing novel treatments for ocular disorders, such as glaucoma. Under the terms of the agreement, Astellas may pay up to £85 million ($1
- Ivantis Receives FDA Approval for the Hydrus Microstent for Minimally Invasive Glaucoma Surgery (MIGS)https://modernod.com/news/ivantis-receives-fda-approval-for-the-hydrus-microstent-device-for-minimally-invasive-glaucoma-surgery-migs/2479950/Ivantis announced that it has received FDA approval for the Hydrus Microstent, a microinvasive glaucoma surgery (MIGS) device used to treat patients with mild to moderate primary open-angle glaucoma in conjunction with cataract surgery. “The Hydrus represents a unique next-generation
- Australian Research Lifts the Lid on Lipids to Prevent Dry Eyehttps://modernod.com/news/australian-research-lifts-the-lid-on-lipids-to-prevent-dry-eye/2479951/Australian researchers have made an important breakthrough in understanding the composition of the tear film that protects the eyes, leading to more effective treatments for dry eye disease. The project was a collaboration between researchers at University of Wollongong, QUT and the Univ
- Glaukos Announces Pharmaceutical Development Agreement with D. Western Therapeutics Institutehttps://modernod.com/news/glaukos-announces-pharmaceutical-development-agreement-with-d-western-therapeutics-institute/2479956/Glaukos announced it has entered into a research and development collaboration agreement with D. Western Therapeutics Institute (DWTI), a Japanese biotechnology company focused on the discovery and development of innovative new drugs to serve patients worldwide. Under the agreement, Glauko
- Ocutech Introduces New Ves Falcon Autofocus Bioptic Telescopehttps://modernod.com/news/ocutech-introduces-new-ves-falcon-autofocus-bioptic-telescope/2479963/Following 6 years of development and testing, Ocutech has introduced its new VES Falcon Autofocus Bioptic Telescope, the company’s next generation autofocusing bioptic for the visually impaired. The Falcon is in initial limited release with select low-vision specialists in the United
- Guardion Health Sciences Receives Methods Patents to Standardize Vision Testinghttps://modernod.com/news/guardion-health-sciences-receives-methods-patents-to-standardize-vision-testing/2479965/On July 10 and July 17, 2018, Guardion Health Sciences was issued two patents by the United States Patent and Trademark Office, both entitled “Method and Apparatus for Visual Acuity Testing.” The first pat
- Imprimis Announces Clinical Trial for Dropless TriMoxi Formulation in Canadahttps://modernod.com/news/imprimis-announces-clinical-trial-for-dropless-trimoxi-formulation-in-canada/2479968/Imprimis Pharmaceuticals announced that its Canadian partner, Advanced Dosage Forms, will begin enrolling patients at McGill University Health Centre (MUHC) for a clinical trial of Imprimis’s leading Dropless (triamcinolone acetonide-moxifloxacin) formulation aft
- Glaucoma Research Foundation Grant Leads to Breakthrough in Neuron Regenerationhttps://modernod.com/news/glaucoma-research-foundation-grant-leads-to-breakthrough-in-neuron-regeneration/2479971/The Glaucoma Research Foundation announced a team of neuroscience researchers, led by Adriana Di Polo, PhD, at the University of Montreal, have made a major breakthrough in the treatment of glaucoma. The research, which was made possible by a Glaucoma Research Foundation Shaffer Grant, could also
- Family Income, Ethnicity, and Health Literacy May Affect Children’s Vision, Eye Care Accesshttps://modernod.com/news/family-income-ethnicity-and-health-literacy-may-affect-childrens-vision-eye-care-access/2479982/August for many children in the United States is the beginning of a brand new school year. According to the recent report from the National Center for Children’s Vision and Eye H